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Abstract
Tissue engineering has been viewed as a valid approach toward the partial or total 
replacement of defective tissues and organs. Recent advances in nanotechnology have 
made it possible to develop biocompatible materials at the micro- and nano-scales to 
be used as scaffolds for cellular growth and regeneration of defective tissues. Gastric 
mucosal lining is an example of soft tissues that are highly susceptible to damage due to 
various reasons including cancer or ulcer development. Current therapeutic approaches 
to these diseases have some limitations. This chapter describes the basis for development 
of a novel modality combining nanotechnology, stem cells, and tissue engineering for the 
replacement of defective gastric tissues using synthetic biocompatible scaffolds. These 
microfibrous scaffolds are seeded with gastric stem cells, which are studied for their pro-
liferation and differentiation into functional gastric mucous cells.
Keywords: gastric stem cells, mucous neck cells, electrospinning, porous microfibrous 
scaffold, tissue regeneration
1. Introduction
Gastric cancer remains the second or third largest cause of cancer-related mortality world-
wide [1, 2]. The standard operation for early or advanced gastric cancer is partial or radical 
gastrectomy. Patients after gastrectomy suffer from various complications such as dumping 
syndrome and pernicious anemia. These conditions are attributed to the loss of storage, diges-
tive, and exocrine glandular functions of the stomach such as secretion of gastric enzymes, 
acid and intrinsic factor [3]. More than two-third of gastric cancer cases are unresectable and 
their response rate to chemotherapy is very low. Cases subjected to gastrectomy have less 
than 30% chance of 5-year survival [4, 5].
© 2017 The Author(s). Licensee InTech. This chapt r is distributed under the terms of the Creative Comm s
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The stomach is the most dilated part of the digestive tube, which connects the esophagus with 
the small intestine (Figure 1). The wall of the stomach comprises four coats: serosa, musculosa, 
submucosa, and mucosa. The outermost serosa layer represents the peritoneal covering of the 
stomach. The luminal surface of the stomach has innumerable micro-openings for gastric pits 
(foveolae) continuous with the isthmus, neck and base of the gastric glands. In the cardia and 
pyloric regions, these glands are mostly populated by mucous cells and some enteroendo-
crine cells. However, the corpus glands are populated by two different types of mucous cells 
(pit and neck cells), pepsinogen-secreting chief or zymogenic cells, acid-secreting parietal 
cells, and hormone-secreting enteroendocrine cells (Figure 1). All these cells originate from 
stem cells residing in the isthmus region of the gastric glands. In addition to the role of these 
stem cells in physiological maintenance of the heterogeneous epithelium of the gastric gland, 
these cells are necessary for regeneration, healing, and repair of the gastric mucosa.
Although some gastric replacement approaches have been proposed to improve the quality 
of life of patients after gastrectomy, the optimal reconstruction procedure remains contro-
versial [6]. Recent advances in the field of tissue engineering allowed fabrication of many 
tissues and organs. As an alternative remedy to the post-gastrectomy complications, gastric 
mucosal tissue engineering has been proposed. It has long been believed that the stomach 
never regenerates once it has been resected [7]. However, tissue-engineered stomach is an 
attractive solution post-gastrectomy to restore an adequate food digestion and appropriate 
gastric physiology.
Figure 1. Diagrams depicting the structure of the stomach and gastric epithelial unit including the pit and three 
glandular regions: isthmus, neck and base. Note that stem cells and their immediate descendants are located in the 
isthmus. Surface mucous, mucous neck, and zymogenic cells are located in the pit, neck, and base, respectively. Parietal 
and enteroendocrine cells are scattered throughout.
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Studies on tissue engineering of the stomach are very limited. This may be attributed to the 
unique geometry and biomechanics of the stomach compared to other soft tissues. There are 
some reports on syngeneic and autologous tissue-engineered stomachs in Lewis rats [8–11] 
and Yorkshire swine [12], respectively. Although these studies demonstrated a regenerated 
epithelium organized into gastric glands, epithelial differentiation, and proliferation were not 
comprehensively analyzed. In addition, investigations involving the mechanism of formation 
of these tissue-engineered gastric glands are lacking.
Tissue engineering is an interdisciplinary field that combines the knowledge and technology 
of materials design and optimization, cell cultures, and appropriate use of growth or bio-
chemical factors to create artificial tissues, and regenerate damaged organs [13–22]. Examples 
of organs that have been tissue engineered include urinary bladder [23], trachea [24, 25], ure-
thra [26], heart [27], liver [28–30], and lung [31, 32].
For tissue engineering, stem cells are derived from a patient, cultured to increase their num-
ber, seeded onto a certain carrier or a “scaffold,” and then incubated in vitro to cellular inte-
gration and differentiation. The appropriate factors are also added to the culture system and 
over a relatively short time, a new tissue is formed. This newly developed tissue is finally 
ready for implantation to restore the function of a defective organ in a patient [33]. By defini-
tion, a scaffold is a three-dimensional (3D) porous construct with pre-tailored architecture 
and internal morphology that serves as a template for tissue regeneration [34]. It also serves 
as a carrier for cells, growth factors, or other biomolecular signals. Being porous in nature, a 
scaffold directs the growth of cells either seeded within its porous structure or migrating from 
surrounding tissue. Many studies demonstrated the fabrication of scaffolds with different 
structure and topography.
Electrospinning is a versatile processing technique that can be used for the fabrication of 
random and aligned fibrous scaffolds with fibers of average diameter in the nm- or μm-scale. 
The technique utilizes an applied voltage (up to 30 kV) to overcome the surface tension forces 
of a polymer solution, hence causing it to stretch into fibers that are deposited on a grounded 
metallic substrate (Figure 2) [35, 36]. Various materials have been electrospun into micro- and 
nano-fibers using electrospinning for a wide range of applications. In tissue engineering, a 
fibrous scaffold made by electrospinning closely matches the morphology of the extracellular 
matrix; hence, this increases its potential for tissue regeneration applications. Moreover, the 
interconnectivity of the pores in 3D-fibrous scaffolds made by electrospinning enhances the 
communication between the cells in culture, and facilitates their proliferation and differentia-
tion. In contrast, cells grown on 2D platform can proliferate but their differentiation potential 
would be limited [37].
Various studies developed 3D porous scaffold systems that were either cells-free (acellular) 
or containing different types of cells. In the acellular approach, cells-free porous scaffolds are 
implanted inside the internal lining of the stomach to promote the formation of new gastric 
tissues. Examples included a porous poly(glycolic acid)-reinforced collagen scaffold with a 
silicone sheet covering the luminal side of the stomach [7, 38]. These batches incompletely 
supported tissue regeneration of the muscular layer and the patch grafts contracted signif-
icantly over time. An alternative scaffold composition was developed by Araki et al. and 
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was composed of poly(D,L-lactide), poly(ε-caprolactone) (PCL), collagen, and poly(glycolic 
acid) nonwoven fabric [39]. This multi-layer scaffold was used to repair a large stomach 
wall defect in a dog without infection or anastomotic dehiscence, and showed sufficient 
mechanical strength for suturing and better biocompatibility. However, early shrinkage of 
the implanted scaffold was eventually observed and regeneration of the muscle layer did 
not occur. In another study, Lourenco et al. developed a model comprising a gastric stromal 
cell line (NST-20) embedded in a 3D alginate-RGD hydrogel prepared on the basolateral side 
of a Transwell insert. This assembly closely mimicked the extracellular matrix of the gastric 
mucosa. It was used for the growth of a moderately differentiated gastric adenocarcinoma 
cell line (MKN28). This cell-containing scaffold was capable of reproducing the physiological 
conditions of the gastric barrier [40]. Lourenco et al. proved the closer similarity of this model 
to the native structure of the gastric mucosa, in which stromal cells appeared to have a role 
in the establishment of mucosal architecture. This was further confirmed by the production 
of extracellular matrix. In a different study, isolated gastric epithelial units were seeded onto 
the inner luminal surface of microporous biodegradable polymer tubes. These tubes were 
made from a fibrous, nonwoven mesh made of polyglycolic acid and coated with 5% poly-L-
lactic acid. The seeded polymer tubes were completely wrapped and sutured into the omen-
tum of adult Lewis rat. These gastric unit/scaffold constructs formed cyst-like structures, 
which were called “tissue-engineered stomachs” [41]. Recently, Noguchi et al. developed 
a method to induce the formation of stomach organoids from mouse embryonic stem cells. 
In this regard, gastric primordial epithelium and underlying mesenchyme were developed 
using a Matrigel-based 3D culture system. The differentiated organoid were found to contain 
both corpus- and antrum-specific mature gastric epithelial cells [42]. Finally and in another 
recent study, scientists grew tissues from the stomach’s corpus/fundus region in a petri dish, 
which were able to produce hydrochloric acid and digestive enzymes [43]. This took place 
through differentiation of human pluripotent stem cells into gastric organoids containing 
fundic epithelium [43].
Figure 2. A schematic diagram of the electrospinning process.
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Recently, in our lab, a 3D scaffold made of a biodegradable PCL was fabricated by an elec-
trospinning technique and was used for the growth and differentiation of gastric stem cells 
[44]. The main objective was to develop the basis for a new modality for the regeneration of 
defective gastric tissue as a result of gastric cancer or severe gastric ulcer. The experimental 
procedures and results of this 3D model system are summarized below.
2. Experimental procedures
2.1. Scaffolds preparation and characterization
PCL with an average molecular weight (M
n
) of 70,000–90,000 by GPC was used for preparing 
scaffolds for gastric stem cell culture. An electrospinning technique operating at an applied 
voltage of 12 kV, a spinning distance of 14 cm, and a feeding rate of 0.16 mL/min, was used 
in making porous PCL scaffolds. Scaffolds were characterized for their microstructure using 
a scanning electron microscopy (SEM) technique operating at 15 kV. Tensile properties of the 
PCL fibrous scaffolds were measured using a universal testing machine MTS with a load cell 
of 100 kN with an overhead speed of 5 mm/min at room temperature. The measurement of the 
tensile strength was done in triplicate according to published protocol [45]. For comparison, 
the stomach wall of 6-month-old mice (n = 3) was used after washing in cold phosphate buff-
ered saline (PBS). Tissues were immediately tested for their tensile strength. Before and after 
the tensile tests, SEM examination was conducted to investigate the effect of applied load and 
deformation on the surface topography of the scaffolds.
2.2. Culture of mouse gastric stem (mGS) cells
PCL microporous scaffolds were sterilized with various degrees of ethanol solutions and 
completely dried prior cell culture experiments. The mGS cells were seeded (2.5 × 105 cells) 
onto scaffolds (15 mm diameter and 0.9 mm thickness) placed in a 12-well plate, and allowed 
to grow in a 37°C incubator containing 5% CO
2
 and 95% O
2
 for up to 12 days. The serum-
containing RPMI culture medium was changed every 48 hours. After 3 days in culture, cells 
were processed for initial screening of cell viability and for microscopic examinations using 
an inverted Olympus microscope, and Phillips SEM. For SEM, fixation was in 4% parafor-
maldehyde for 15 min and post-fixation, in 1% osmium tetroxide for 10 min. Following dehy-
dration in ethanol, cells were processed for gold-palladium coating, and finally examined 
with SEM.
After 3, 6, 9, and 12 days, cultured cells were processed for the quantification of DNA. Cells 
were washed with PBS and stored at −80°C in 1 ml of Milli-Q water. DNA was extracted 
from the samples by repeated freeze-thaw cycles followed by ultrasonication. The Quant-iT 
PicoGreen dsDNA kit was used to quantify DNA according to the manufacturer’s instruc-
tions. The fluorescence intensity was measured at 520 nm by using the PerkinElmer reader. 
Scaffolds without cells were used as blank samples. For the measurement of statistical signifi-
cance, a one way ANOVA with Tukey Multiple Comparison Test was used.
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2.3. Immuno- and lectin-cytochemical analysis
The mGS cells cultured on scaffolds for 3 and 9 days were fixed for 15 min in 4% paraformal-
dehyde. Following PBS wash, cell-containing scaffolds were processed for overnight incu-
bation in 20% buffered sucrose at 4°C. The scaffolds were then mounted on an aluminum 
stalk using Shandon Cryomatrix. Frozen sections (10–30 micron-thick) were obtained using 
Cryostome FSE cryostat and immediately mounted on gelatin-coated slides. To visualize cel-
lular morphology and orientation, a few sections were stained with hematoxylin and eosin. 
The adjacent sections were processed for lectin cytochemistry and immunoprobing of cellu-
lar-specific biomarkers.
Following incubation with blocking solution, cryosections were incubated for 60 min with 
different fluorophore-conjugated lectins: Ulex europaeus agglutinin (UEA) I (specific for sur-
face mucous cells), Griffonia simplicifolia (GS) II (for mucous neck cells), or Dolichos biflorus 
agglutinin (DBA, for parietal cells) [46, 47]. Cryosections of cell-containing scaffolds were also 
incubated overnight with several antibodies specific for H,K-ATPase alpha and beta subunits 
(for parietal cells), TFF1 (for surface mucous cells), TFF2 (for mucous neck), chromogranin-A 
(for enteroendocrine cells), and ghrelin (for a subtype of enteroendocrine cells). Probed sec-
tions were washed in PBS and the appropriate fluorophore-conjugated secondary antibody 
was added. Finally, cells were visualized using Olympus fluorescence microscope or Nikon 
confocal microscope.
3. Results and discussion
PCL scaffolds made of microfibers in the range of 2–3 μm in diameter were prepared by 
electrospinning (Figure 3). The scaffold is characterized by a homogeneous fiber size dis-
tribution and interconnected porosity. These features are strongly recommended for tissue 
engineering applications, where the small size fibers provide high surface area for better cell 
adhesion, while the interconnected porosity provides pathways for cell interaction and new 
tissue formation. Figure 4 shows a comparison between the tensile strength of a pure PCL 
microfibrous scaffold and that of a mouse stomach tissue. On one hand, synthetic scaffold 
showed a variable degree of tensile strengths at a higher range (0.35–0.6 MPa) than that of 
natural gastric tissues (0.22 MPa). On the other hand, both synthetic scaffold and natural 
stomach tissues showed a high degree of elasticity. These properties indicate the suitability 
of the PCL fibrous scaffold to replace the natural gastric tissues. More importantly, the higher 
strain of the PCL fibers makes them more durable to expansion and contraction, as dictated 
by the stomach biomechanical properties. While electrospun PCL fibers appeared nonwoven 
with random distribution (Figure 3), they re-align upon applying tensile forces. This feature 
is attributed to the interconnected porosity that allows the re-orientation of the fibers during 
tensile strength measurement.
Microscopic examination of the toluidine blue-stained mGS cells revealed their variable 
appearance on the PCL microfibrous scaffold [44]. When examined with SEM, they tend to 
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appear flattened [44] with cytoplasmic processes spanning the space between microfibers. 
Therefore, mGS cells were attached to more than one microfiber and integrated into the pores 
of the scaffold to grow in 3D (Figure 5).
Studies on the surface topography and porosity of scaffolds demonstrated their role on cellular 
adhesion, growth, and differentiation. Inducing abrasions on the surface of polyvinyl alcohol 
improved orientation/elongation of fibroblasts and cardiac muscle cells [48]. Different types 
of scaffolds with variable geometries have been tested for cell culture and adequate growth. 
Figure 3. A scanning electron micrograph showing the PCL microfibrous scaffold (insert: a higher magnification of the 
fibers).
Figure 4. Stress-strain curves showing the tensile strengths of a synthetic PCL microfibrous scaffold (a), and a natural 
mouse stomach issue (b).
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The electrospun scaffolds with microfibers seem to be the most suitable because of their 3D 
architecture, large surface area, and interconnected porosity. It was shown previously that 
PCL fibrous scaffolds support proliferation and differentiation of mesenchymal stem cells 
extracted from periodontal ligament [49, 50] and oligodendrocyte precursor cells [51]. Some 
studies showed that the fiber diameter could influence cell function and behavior on the scaffold 
[52–57]. Porosity is also an important factor for transport of nutrients and metabolites [58, 59].
Based on the above information, the mechanical and topographical characteristics of the 
microfibrous scaffold, cell viability and DNA quantification assays were conducted. Both 
Calcein and MTT cell viability assays showed that microfibrous scaffold support mGS cell 
growth. The DNA PicoGreen assay was also used to estimate the amount of cells and con-
firmed the advantage of the fibrous nature of the scaffold in promoting mGS cell binding and 
growth. It is known that cells interact with the extracellular matrix via integrin binding and 
sense difference in mechanical stresses through integrin signaling pathway. It was shown 
that increasing porosity is associated with increasing the expression of integrins [60]. This 
could partly explain the results obtained in the present study and the value of high porosity 
of microfibrous scaffold and their significant support to mGS cell growth and attachment.
The mGS cells were seeded on the PCL microfibrous scaffolds for 3, 6, 9, and 12 days to deter-
mine their pattern of growth as a function of time. The DNA was extracted from attached cells 
at different time points and quantified by using PicoGreen assay. The data reflected the num-
ber of attached cells on the scaffolds at 3 to 12 days of culture. Figure 5 in [44] showed that the 
amount of DNA increased from day 3 to day 6 indicating proliferation of mGS cells on the scaf-
folds. However, when the cells were cultured for 9 days, the amount of DNA was significantly 
reduced. A reduction in the amount of DNA was also observed in cells cultured for 12 days 
[44]. This decrease in the number of cells is either due to down-regulation of cell proliferation 
or cell death. This effect could be regulated by integrins cytoplasmic domains that are known 
to affect cell proliferation [61]. Integrin’s extracellular domain is also involved in adhesion 
through interactions with laminin [62]. Targeted deletion of the cytoplasmic domain of integrin 
Figure 5. Diagrammatic representation of the microfibrous PCL scaffold immersed in the culture media before and 
after seeding with mGS cells. Note that the fibrous structure of the scaffold allows the cells to integrate through its 
interconnected pores and grow in 3D.
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induced reduction in cell proliferation and cell cycle arrest [63, 64]. The microfibers of scaffolds 
are made of inert material and lack the integrin binding sites. Therefore, the modification in the 
mGS cell cycle signaling is not expected for mGS cells growing on microfibrous PCL scaffolds. 
It was interesting to find that the reduction in cell proliferation after 9-day culture was associ-
ated with an increase the size of mGS cells [44] which could suggest cell differentiation with 
even loss of some of the differentiated cells. To test whether the decrease of cell number and 
the associated cellular enlargement were due to differentiation, cryostat sections of mGS cell-
containing scaffolds of 3 and 9 days were processed for antibody probing and lectin binding. 
Expressions of lineage-specific proteins and glycoconjugates were taken as an indication of cell 
differentiation. Cryosections stained with hematoxylin and eosin demonstrated general mor-
phology [44]. Adjacent sections probed with anti-TFF2 antibodies revealed that after 9 days of 
culture of mGS cells on scaffolds, some cells synthesized TFF2 specific for mucous neck cells 
[65, 44]. When adjacent sections were incubated with a lectin specific for mucous neck cells 
(GSII), the results revealed positive binding to GSII lectin as seen with fluorescence [44] and 
confocal [44] microscopes. Therefore, these findings demonstrate that PCL microfibrous scaf-
folds are suitable for growth and differentiation of mGS cells into mucous neck cells.
4. Conclusions
A synthetic biocompatible microfibrous scaffold made of PCL and fabricated by an electrospin-
ning technique has been used for the culture of mGS cells. The scaffold is characterized by its 
high surface area and interconnectivity of its 3-dimensional porosity. These factors were shown to 
provide suitable construct for the proliferation and differentiation of mGS cells. Results showed 
the continued growth of the mGS cells for 6 days, followed by differentiation at 9 days. Histo- and 
immunocytochemistry measurements combined with SEM analysis showed multiple evidences 
in support of the differentiation of the gastric stem cells to mucous neck cells. These results provide 
the basis for a valid potential application of tissue engineering for regeneration of gastric tissues.
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